|Year : 2011 | Volume
| Issue : 2 | Page : 147-151
Risk factors for acquiring Strongyloides stercoralis infection among patients attending a tertiary hospital in south India
P Chordia1, S Christopher2, OC Abraham3, J Muliyil4, G Kang5, SSR Ajjampur5
1 Department of Internal Medicine, University of Florida, Gainesville, FL 32610, India
2 Department of Biostatistics, Christian Medical College, Vellore - 632 004, India
3 Department of Medicine, Christian Medical College, Vellore - 632 004, India
4 Department of Community Health, Christian Medical College, Vellore - 632 004, India
5 Department of Gastrointestinal Sciences, Christian Medical College, Vellore - 632 004, India
|Date of Submission||10-May-2010|
|Date of Acceptance||23-Mar-2011|
|Date of Web Publication||2-Jun-2011|
Department of Gastrointestinal Sciences, Christian Medical College, Vellore - 632 004
Source of Support: Fluid Research grant from Christian Medical College, Vellore, Conflict of Interest: None
Purpose: Strongyloides stercoralis causes persistent and fatal disseminated infections in immunocompromised hosts. In this study, we aimed to determine the risk factors for acquiring strongyloidiasis and the associated morbidity in south India. Materials and Methods: The study was carried out in two parts. This included a 6-month chart review of cases with strongyloidiasis and randomly selected controls conducted to determine the association with immunocompromised states. Secondly, a cross-sectional study was conducted to investigate hyperinfection in human immunodeficiency virus (HIV)-infected adults where the stool and sputum samples were examined by microscopy for Strongyloides larvae. Results: In the chart review, 118 cases were compared with 240 controls. A higher proportion of patients on corticosteroids [8 (53.3%)] and with HIV infection [3 (60%)] had the risk of acquiring strongyloidiasis than not, although the difference was not statistically significant in this population. In the cross-sectional study, 14/239 HIV-positive individuals had Strongyloides larvae in the stool samples but none had Strongyloides detectable in their sputum samples. The CD4 cell counts were significantly lower in cases with Strongyloides compared with HIV-infected individuals with no parasites in their stool samples (P < 0.001). Conclusions: In this setting, strongyloidiasis was seen more often in patients on corticosteroid therapy and with HIV infection. In HIV, an association with lower CD4 counts indicates the need for inclusion of Strongyloides as an opportunistic parasite. Gram negative sepsis was an important complication of strongyloidiasis hyperinfection in both HIV and steroid therapy. Further prospective studies on the risk of developing complicated Strongyloides infection are required.
Keywords: Disseminated strongyloidiasis, Gram negative sepsis, human immunodeficiency virus, hyperinfection, immunosuppression, Strongyloides stercoralis
|How to cite this article:|
Chordia P, Christopher S, Abraham O C, Muliyil J, Kang G, Ajjampur S. Risk factors for acquiring Strongyloides stercoralis infection among patients attending a tertiary hospital in south India. Indian J Med Microbiol 2011;29:147-51
|How to cite this URL:|
Chordia P, Christopher S, Abraham O C, Muliyil J, Kang G, Ajjampur S. Risk factors for acquiring Strongyloides stercoralis infection among patients attending a tertiary hospital in south India. Indian J Med Microbiol [serial online] 2011 [cited 2019 Dec 8];29:147-51. Available from: http://www.ijmm.org/text.asp?2011/29/2/147/81797
| ~ Introduction|| |
Strongyloides stercoralis is a soil-dwelling nematode, which alternates between the free-living and the parasitic stage, and affects an estimated 100-200 million individuals worldwide. Warm moist temperatures, lower socioeconomic status and poor sanitation leading to faecal contamination of soil have contributed to the increased prevalence of strongyloidiasis in the tropics.  Several risk factors have been associated with strongyloidiasis, including immunosuppressive therapy for rheumatic disease, malignancy (especially lymphomas), transplants, human immunodeficiency virus (HIV) infection, HTLV-1 infection, diabetes, hypochlorhydria, alcoholism, tuberculosis, impaired bowel motility, malnourishment,  chronic obstructive pulmonary disease,  leprosy  and chronic renal failure. 
In individuals at risk, the overwhelming autoinfective cycle can lead to a life-threatening illness due to hyperinfection or disseminated syndrome, with large numbers of larvae affecting the gastrointestinal tract, peritoneum and lungs. Sepsis, another complication of strongyloidiasis, occurs when enteric bacteria gain access into the extraintestinal sites, either by carriage on the surface of the filariform larvae or by entry through mucosal ulcers induced by the larvae. It is a fatal complication of hyperinfection syndrome reported to occur in 12-60% of the cases. , Blood cultures from these patients have grown Escherichia More Details coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Enterococcus faecalis, Streptococcus epidermidis, Streptococcus bovis and Streptococcus pneumoniae. 
Although there have been many case reports on Strongyloides stercoralis infection in India, , few studies have identified the predisposing risk factors for acquiring this infection. In the present study, we attempted to identify the predisposing risk factors for strongyloidiasis and the prevalence and complications of Strongyloides in HIV-infected subjects in India.
| ~ Materials and Methods|| |
The study was conducted in a 2,200-bed, tertiary care hospital in southern India and comprised of two parts - a chart review and a cross-sectional study. The study was funded by a small institutional grant and was IRB approved.
A 6-month chart review of cases with strongyloidiasis and controls without strongyloidiasis was carried out to determine the association with different immunocompromised states, including HIV infection among Indian patients. Cases identified as positive for Strongyloides larvae by wet mount microscopy were enrolled using the laboratory database. The control group comprised of the first two stool samples received each day that were negative for Strongyloides larvae during the same time period. Risk factors associated with strongyloidiasis reviewed included (i) HIV infection, (ii) use of corticosteroid therapy, (iii) malignancy, (iv) solid organ and haematological stem cell transplants, (v) diabetes mellitus, (vi) chronic obstructive pulmonary disease (COPD), (vi) tuberculosis, (vii) leprosy, (viii) hypochlohydria and (ix) chronic renal failure and other chronic diseases, which included hepatitis, chronic heart disease, chronic pancreatitis and mucormycosis. The presence of concomitant infections, including sepsis, was also recorded in the cases and controls. As none of the subjects was tested for HTLV-1 infection, it was not included in the risk factor analysis. Alcohol was also not included as a risk factor as history for alcohol intake was not well elucidated in the patient charts.
To determine the prevalence of hyperinfection and dissemination syndrome and its association with Gram negative sepsis in HIV-positive individuals, a cross-sectional study was conducted on HIV-positive cases attending the inpatient and outpatient services. All subjects once enrolled provided a stool sample and blood for CD4 counts. If the stool sample was positive for Strongyloides larvae, a sputum sample was also collected. To determine the outcome, subjects were followed-up for a 6-month period after the diagnosis of strongyloidiasis by a review of medical charts.
Stool samples collected were screened for the presence of Strongyloides larvae using wet mount microscopy. Larvae were identified as Strongyloides rhabditiform (~300 μm in length, short buccal cavity with a prominent genital primordium) or filariform (~500 μm in length, long oesophagus and a notched tail) stages in order to differentiate them from hookworm larvae.  Gram staining was carried out to identify the filariform stages in the sputum samples collected. Blood samples were examined for CD4 counts using the FACScount analyzer (Becton Dickinson, Franklin Lakes, NJ, USA).
Continuous variables were described using mean ± standard deviation and variables that are skewed were presented using median and range. Chi-square test was used to assess the associations between categorical variables and t-test was used to compare the continuous variables between the two groups. Mann-Whitney test was used for comparison of continuous variables that were skewed. All statistical analyses were performed using SPSS 11.0 for windows. A P-value <0.05 was considered statistically significant.
| ~ Results|| |
In the 6-month chart review conducted from January to June 2006, 118 cases found to have stool samples positive for Strongyloides were compared with 240 controls whose stools were negative for Strongyloides during the same period. The age of the cases was (mean ± SD) 44.1 ± 13.2 years while that of the controls was 41.5 ± 15.6 years, indicating that age did not predispose to the development of S. stercoralis infection (P = 1.20). Male gender was, however, significantly associated with strongyloidiasis (P = 0.003). There was also a strong positive correlation between hookworm and Strongyloides infections (P < 0.001). For 82 of the 118 cases and 169 of the 240 controls, eosinophil counts on peripheral smears were available and, when compared, there was a significant difference between the cases (median, IQR (25-75)% , 7, 10.5) and the controls (3, 4) (P < 0.001) as expected to occur during an invasive parasitic infection. [Table 1] shows the proportion of cases and controls with one or more than one risk factor and [Table 2] shows the results of comparison of risk factors occurring in cases and controls. The prevalence of various risk factors considered to predispose to strongyloidiasis showed no statistically significant difference between the cases and controls. However, a higher proportion of patients on corticosteroids for rheumatic disease/inflammatory bowel disease (n = 8, 53.3%) and those with HIV infection (n = 3, 60%) had strongyloidiasis than not (n = 7, 46.7% and n = 2, 40%, respectively).
|Table 1: Proportion of cases and controls with predisposing factors to strongyloidiasis in the chart review|
Click here to view
|Table 2: Predisposing factors associated with strongyloidiasis in cases and controls in the chart review|
Click here to view
Of the 118 cases, one subject was found to have Strongyloides hyperinfection complicated with Gram negative sepsis. She was a 16-year-old woman with previously diagnosed systemic lupus erythematosus (SLE) on oral daily dose of prednisone. Prior to starting corticosteroids, an initial stool examination was not conducted. She developed three episodes of Strongyloides hyperinfection syndrome, diagnosed by the presence of multiple filariform larvae in her stool and sputum samples, the last one being complicated by E. coli septicaemia and causing subsequent death. The first two episodes were treated with albendazole. Ivermectin was administered when she presented for the third time with hyperinfection.
Cross-sectional Study on HIV-Infected Adults
In the cross-sectional study, conducted from July 2006 to March 2008, 239 HIV-positive individuals were enrolled. Stool parasites were detected in 43 of the 239 HIV patients, 14 (5.86%) of whom had Strongyloides larvae. The other parasites seen were Cryptosporidium spp. (4.18%), Isospora belli (3.35%), hookworm (3.35%), Giardia lamblia (2.5%), Ascaris lumbricoides (1.25%), Hymenolepis nana (0.4%), Enterobius vermicularis (0.4%) and Trichuris trichiura (0.4%). None of the Strongyloides cases had sputum smears that were positive for larvae. All the 14 subjects infected with strongyloidiasis were male, and the mean age ± SD of the cases was 35.14 ± 4.79, which was similar to HIV-positive individuals with no parasites or other parasites in their stool samples (P = 0.379). CD4 cell counts were available for 162/239 HIV patients [Figure 1], and were found to be significantly lower in HIV-infected individuals with strongyloidiasis (median, IQR 25-75%, 80.5 cells/μl, 69) as compared with HIV-infected individuals with no parasites in their stool samples (301 cells/μl, 334) (P < 0.001). The CD4 counts of HIV patients infected with opportunistic coccidian parasites, including Cryptosporidium (63 cells/μl, 140) and Isospora (109 cells/μl, 180), were comparable to that of patients with strongyloidiasis. In addition, 10 of these 14 cases were diagnosed with HIV at the time of or within a month of detection of Strongyloides larvae.
|Figure 1: CD4 counts in human immunodefi ciency virus-infected patients with and without stool parasites in the cross-sectional study (n = 162)|
Click here to view
Six months after the initial visit, eight of the 14 patients were available for follow-up and six of those lost to follow-up did not return to the hospital. One of the eight cases that were followed-up developed Gram negative infection on follow-up. He was a 35-year-old male who presented with a 2-week history of low-grade intermittent fever, cough with expectoration, loss of appetite and loss of weight and was diagnosed to have disseminated tuberculosis. His CD4 cell count was 56 cells/μl and he was not on antiretroviral therapy. He developed sudden-onset high-grade fever and his blood culture grew E. coli, but no focus of infection was found. Stool wet mount microscopy was performed, which showed multiple S. stercoralis larvae. However, his sputum on Gram staining was negative for S. stercoralis larvae. He was treated with amikacin and ivermectin and was stable on discharge. Due to the acute exacerbation of fever, E. coli septicaemia and presence of multiple larvae in his stool, he was diagnosed to have hyperinfection syndrome. This patient along with four others was started on antiretroviral therapy and all these have had no major illness since then. No major morbidity or mortality was reported in the remaining three cases not on antiretroviral therapy on follow-up.
| ~ Discussion|| |
The purpose of this study was to identify the predisposing risk factors for acquiring Strongyloides infection and to determine the incidence of hyper- and disseminated infections along with associated complications in HIV patients in an Indian setting. Previous reports from India have shown that prevalence of strongyloidiasis in HIV-infected patients ranged from 0 to 5.3%, although one study conducted in northeastern India showed a high prevalence of 27.3%. ,, We found that patients on corticosteroid therapy or with HIV infection had strongyloidiasis more often. In this study, CD4 cell counts of HIV-positive patients with strongyloidiasis were significantly decreased compared with HIV-positive patients with no parasites, and was similar to the CD4 cell counts of patients with opportunistic protozoan infections, including Cryptosporidium and Isospora. A study from Thailand also reports an increased prevalence of Strongyloides in HIV-positive cases with CD4 counts less than 100 cells/μl. These data along with the finding that in a majority of the cases Strongyloides larvae was identified at or around the time of detection of HIV suggest that although strongyloidiasis is not listed as an opportunistic infection in HIV,  there may be a need to re-explore whether this exclusion is justified in endemic regions. The TH2 response, promoted by helminth infections including Strongyloides spp., with suppression of TH1 function and decrease in CD4 cell counts may be an alternative cause for the low CD4 cell counts in HIV patients with strongyloidiasis in this study.  Such an interaction between Strongyloides and HTLV-1 infection has been well documented. 
Our study and those of others have found that Gram negative sepsis was an important complication attributable to Strongyloides in individuals on steroid treatment  and with HIV.  Although there have been fewer than 30 reports of complicated Strongyloides cases in HIV-infected patients,  hyper- and disseminated infection in HIV does exist.  Complicated strongyloidiasis following initiation of antiretroviral therapy as part of immune reconstitution syndrome has also been found to occur.  Our findings highlight the need to conduct regular stool examinations for Strongyloides larvae prior to initiation of corticosteroid therapy and in those with a high risk like HIV infection. Ivermectin has been most successful in the treatment of complicated strongyloidiasis in patients with predisposing syndromes like AIDS.  Other findings of the study were that male gender was strongly associated with strongyloidiasis, which, according to Concha et al., is possibly due to an increased risk of acquiring infection outdoors.  However, unlike other studies, older age group did not seem to predispose to strongyloidiasis.  In India, although there have been no detailed studies that showed a male preponderance, a literature review of around 30 case reports and case series over the last 20 years reveals that a majority were in males (34/38 cases). There was also a significant association between hookworm and Strongyloides infection, and this may be explained by the similar route of infection of the larval stage.
Some of the limitations of the study were that the chart review had only a small number of cases and controls with risk factors, and a higher proportion were apparently healthy individuals possibly due to the endemicity in the region. In the cross-sectional study, HIV-infected patients provided only a single stool or sputum sample and no quantitative analysis was conducted. As the sample size of HIV patients with strongyloidiasis was small, and Strongyloides-negative HIV-positive patients were not examined in detail, the association of Strongyloides infection with concurrent conditions predisposing to infection were not examined.  In addition, sputum examination was carried out as a marker of hyperinfection only in cases that were positive for Strongyloides. On retrospection, we may have missed a few cases that were sputum-positive but stool-negative.
Although there is literature from India on complicated Strongyloides infection in the form of case reports and case series, , this is the first study that has attempted to determine the association of Strongyloides with predisposing factors, including HIV, and prospectively tried to identify the development of hyper- and disseminated infection. In conclusion, the study indicates that, in an Indian setting, strongyloidiasis is common in HIV-positive patients with low CD4 counts and may lead to the development of fatal complicated infection. This study also provides clinical data that could help physicians in the early diagnosis and treatment of strongyloidiasis and prevention of fatal disseminated Strongyloides infection and Gram negative sepsis.
| ~ Acknowledgement|| |
The work was supported by the Fluid Research grant from Christian Medical College, Vellore, India. The funding agency had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.
We thank Mr Charles Livingston who helped in recruitment of patients and Mr M Thyagarajan and Dr Greeshma Chandran who helped in follow-up of the cases.
| ~ References|| |
|1.||Keiser PB, Nutman TB. Strongyloides stercoralis in the Immunocompromised Population. Clin Microbiol Rev 2004;17:208-17. |
|2.||Marcos LA, Terashima A, Dupont HL, Gotuzzo E. Strongyloides hyperinfection syndrome: An emerging global infectious disease. Trans R Soc Trop Med Hyg 2008;102:314-8. |
|3.||Lam CS, Tong MK, Chan KM, Siu YP. Disseminated strongyloidiasis: A retrospective study of clinical course and outcome. Eur J Clin Microbiol Infect Dis 2006;25:14-8. |
|4.||Hachim K, Mortajil F, Chakib A, Ramdani B, Zaid D. Severe anguilluliasis in a chronic haemodialysis patient. Presse Med 2005;34:105-6. |
|5.||Asdamongkol N, Pornsuriyasak P, Sungkanuparph S. Risk factors for strongyloidiasis hyperinfection and clinical outcomes. Southeast Asian J Trop Med Public Health 2006;37:875-84. |
|6.||Agrawal V, Agarwal T, Ghoshal UC. Intestinal strongyloidiasis: A diagnosis frequently missed in the tropics. Trans R Soc Trop Med Hyg 2008;103:242-6. |
|7.||Rajapurkar M, Hegde U, Rokhade M, Gang S, Gohel K. Respiratory hyperinfection with Strongyloides stercoralis in a patient with renal failure. Nat Clin Pract Nephrol 2007;3:573-7. |
|8.||Ash LR, Orihel TC. Parasites: A guide to laboratory procedures and identification. Chicago: ASCP Press; 1987. |
|9.||Dwivedi KK, Prasad G, Saini S, Mahajan S, Lal S, Baveja UK. Enteric opportunistic parasites among HIV infected individuals: associated risk factors and immune status. Jpn J Infect Dis 2007;60:76-81. |
|10.||Joshi M, Chowdhary AS, Dalal PJ, Maniar JK. Parasitic diarrhoea in patients with AIDS. Natl Med J India 2002;15: |
|12.||Singh LA, Chinglensana L, Singh NB, Singh HL, Singh YI. Helminthiasis in HIV infection: A brief report from Manipur, (India). J Commun Dis 2004;36:293-6. |
|13.||Pinlaor S, Mootsikapun P, Pinlaor P, Pipitgool V, Tuangnadee R. Detection of opportunistic and non-opportunistic intestinal parasites and liver flukes in HIV-positive and HIV-negative subjects. Southeast Asian J Trop Med Public Health 2005;36:841-5. |
|14.||Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR Morb Mortal Wkly Rep 1987;36:1S-15S. |
|15.||Kaminsky RG, Soto RJ, Campa A, Baum MK. Intestinal parasitic infections and eosinophilia in an human immunedeficiency virus positive population in Honduras. Mem Inst Oswaldo Cruz 2004;99:773-8. |
|16.||Goon PK, Bangham CR. Interference with immune function by HTLV-1. Clin Exp Immunol 2004;137:234-6. |
|17.||Silva CV, Ferreira MS, Borges AS, Costa-Cruz JM. Intestinal parasitic infections in HIV/AIDS patients: Experience at a teaching hospital in central Brazil. Scand J Infect Dis 2005;37:211-5. |
|18.||Celedon JC, Mathur-Wagh U, Fox J, Garcia R, Wiest PM. Systemic strongyloidiasis in patients infected with the human immunodeficiency virus: A report of 3 cases and review of the literature. Medicine (Baltimore) 1994;73:256-63. |
|19.||Brown M, Cartledge JD, Miller RF. Dissemination of Strongyloides stercoralis as an immune restoration phenomenon in an HIV-1-infected man on antiretroviral therapy. Int J STD AIDS 2006;17:560-1. |
|20.||Orem J, Mayanja B, Okongo M, Morgan D. Strongyloides stercoralis hyperinfection in a patient with AIDS in Uganda successfully treated with ivermectin. Clin Infect Dis 2003;37:152-3. |
|21.||Concha R, Harrington W, Jr., Rogers AI. Intestinal strongyloidiasis: Recognition, management, and determinants of outcome. J Clin Gastroenterol 2005;39:203-11. |
|22.||Lindo JF, Robinson RD, Terry SI, Vogel P, Gam AA, Neva FA, et al. Age-prevalence and household clustering of Strongyloides stercoralis infection in Jamaica. Parasitology 1995;110:97-102. |
[Table 1], [Table 2]
|This article has been cited by|
||Co-infection with Nocardia asteroides Complex and Strongyloides stercoralis in a Patient with Autoimmune Hemolytic Anemia
| ||I. Praharaj,S. Sujatha,M. A. Ashwini,S. C. Parija |
| ||Infection. 2013; |
|[Pubmed] | [DOI]|